• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,200.85 -114.19
( -0.15%)
Global Indices
Nasdaq
49,708.56 161.38
(0.33%)
Dow Jones
7,424.10 -5.40
(-0.07%)
Hang Seng
60,409.17 -406.78
(-0.67%)
Nikkei 225
10,297.25 101.88
(1.00%)
Forex
USD-INR
95.89 0.18
(0.19%)
EUR-INR
111.46 -0.47
(-0.42%)
GBP-INR
127.74 -1.27
(-0.99%)
JPY-INR
0.60 0.00
(-0.28%)

EQUITY - MARKET SCREENER

Vinsys IT Services India Ltd
Industry :  Computers - Education
BSE Code
ISIN Demat
Book Value()
79235
INE0OSJ01014
58.0822667
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VINSYS
39.56
447.68
EPS(TTM)
Face Value()
Div & Yield %
7.71
10
0
 

Supriya Lifescience's manufacturing unit clears USFDA inspection
Apr 22,2026
Supriya Lifescience announced that the U.S. Food and Drug Administration (US FDA) conducted an inspection at the Company's manufacturing facility located at Lote, Parshuram Industrial Area, Maharashtra, India, from 2 February 2026 to 6 February 2026.

The inspection concluded with the issuance of a Form 483 containing one (1) minor observation. The Company has adequately addressed the observation and has received the Establishment Inspection Report (EIR) indicating “Voluntary Action Indicated (VAI)”, signifying a successful completion of the inspection.